Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-HERE: Adherence to topical Advantan in different vehicles for hand eczema
2019-001324-35Phase 4Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of methylprednisolone aceponate in hand dermatitis and atopic dermatitis (AD) (3 arms), sponsored by Friedrich Schiller University Jena. Primary endpoint: Adherence to Advantan treatment. Started Sep 2019; status: completed.
02
Drugs
methylprednisolone aceponate
03
Conditions
hand dermatitisatopic dermatitis (AD)
Beyond the preview
Go deeper on 2019-001324-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001324-35.